Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer.
Affiliation of authors: Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (WFA, PSR, HAK).
William F
WF
Anderson
Affiliation of authors: Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (WFA, PSR, HAK).
Philip S
PS
Rosenberg
Affiliation of authors: Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (WFA, PSR, HAK). katkih@mail.nih.gov.
Hormuzd A
HA
Katki
D001943:Breast Neoplasms / Q000145:classification* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis*; D011960:Receptors, Estrogen / Q000096:biosynthesis*; D011980:Receptors, Progesterone / Q000096:biosynthesis*; D064726:Triple Negative Breast Neoplasms / Q000145:classification* / Q000453:epidemiology*
D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human